Terence J. Colgan MD, FRCSC
Professor Emeritus
Terry J Colgan
Contact Info Website
Mount Sinai Hospital
Appointment Status Cross-Appointed
Cross-appointed: Laboratory Medicine & Pathobiology
Research Interests
hydatidiform mole, molecular genetics

Dr. Colgan is Head of the Sections of Gynecological and Cyto-Pathology at the Mount Sinai Hospital, Toronto, and a Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto.  His practice focuses on gynecologic pathology and cytopathology. His primary research areas are in the screening for gynecologic cancers and diagnosis of gynecologic malignancies.

Both the Canadian Cancer Society Research Institute and the Canadian Institutes of Health Research have provided support for his collaborative research in biomarker discovery in endometrial and head neck cancers, and in fallopian tube carcinogenesis. He is currently serving as Associate Editor of American Cancer Society’s Cancer (Cytopathology), and Chair of the College of American Pathologists’ Curriculum Committee. A synopsis of his professional activities can be found at: www.colganpath.ca


Publications and Awards

View PubMed search of this faculty member's recent publications.

Recent Publications

Abdel-Mesih A, Daya D, Onuma K, Sur M, Tang S, Akhtar-Danesh N, Boutross-Tadross O, Ceballos KM, Chapman W, Colgan TJ, et al. Interobserver agreement for assessing invasion in stage 1A vulvar squamous cell carcinoma. Am J Surg Pathol. 2013;37:1336-41. (Collaborator)

Lytwyn A, Zaino R, Colgan TJ, Otis C. Superficially invasive squamous cell carcinoma of the uterine cervix: the assessment of key parameters. Pathology Case Reviews. 2013; 18: 183 – 89. (Collaborator)

Heller DS, Colgan TJ, Allbritton J. Superficially invasive squamous cell carcinoma of the vulva and vagina. Pathology Case Reviews. 2013; 18: 190 – 94. (Collaborator)

Chang MC, Escallon JM, Colgan TJ. Prognostic significance of a positive axillary lymph node fine-needle aspirate in patients with invasive breast carcinoma. Cancer Cytopath. 2014; 122: 138 – 44.

Kaur J, Matta A, Kak I, Srivastava G, Assi J, Leong I, Witterick I, ColganTJ, et al.  S100A7 overexpression: Predictive marker for high risk of malignant transformation in oral dysplasia. Int J Cancer 2014; 134: 1379 – 88. (Collaborator)

Kolomietz E, Colgan TJ et. al. What are the benefits and barriers to the adoption of a placental molar disease diagnostic service? |Int J Gynecol Pathol (In press)